About · Advisory Board
Guided by expertise. Connected by purpose.
A distinguished group of international scientists, clinicians, legal scholars and deep-tech leaders who support AlbPhD Circle with their expertise, experience and strategic perspective.
The advisors
Prof. Dr. med. Dr. h.c.
Omer Dzemali
University Hospital Zurich & City Hospital Zurich · Switzerland
Clinical Medicine & Translational ResearchProf. Dr.
Arben Merkoçi
ICREA & Catalan Institute of Nanoscience and Nanotechnology (ICN2) · Spain
Bioengineering, Diagnostics & MedTechProf. Dr.
Majlinda Lako
Biosciences Institute, Newcastle University · United Kingdom
Life Sciences & BiomedicineDr. iur., LL.M.
Pranvera Këllezi
Këllezi Legal & Swiss Competition Commission (COMCO) · Switzerland
Institutional Governance & PolicyProf. Dr.
Mira Mezini
Technische Universität Darmstadt & hessian.AI · Germany
AI & Data SciencePD Dr. med. Dr. sc. nat.
Perparim Limani
Kantonsspital Aarau (KSA) · Switzerland
Clinical Medicine & Translational ResearchDr. phil.
Bekim Osmani
Bottneuro AG & University of Basel · Switzerland
Bioengineering, Diagnostics & MedTechCardiovascular surgery & clinical innovation
Prof. Dr. med. Dr. h.c. Omer Dzemali
Chair of Cardiac Surgery, University Hospital Zurich (USZ); Head of the Department of Cardiac Surgery, City Hospital Zurich — Switzerland
Biography
Prof. Dr. med. Dr. h.c. Omer Dzemali is the Chair of Cardiac Surgery at the University Hospital Zurich (USZ), Head of the Department of Cardiac Surgery at the City Hospital Zurich (Triemli), and Leader of the Center for Heart and Vascular Medicine in Zurich. Educated and trained at Goethe University Frankfurt, where he served as Senior Consultant before moving to Switzerland, his clinical and scientific work focuses on less-invasive surgical approaches, complex thoracic aortic procedures and optimizing patient outcomes through state-of-the-art technology and interdisciplinary heart-team collaboration. Beyond his clinical leadership in Switzerland, he plays a pivotal role in modernizing cardiovascular care, medical education and hospital infrastructure in the Western Balkans.
Core expertise
Minimally invasive aortic and mitral valve surgery, robotic cardiac procedures, aortic valve reconstruction, cannulation strategies, clinical trial translation.
2026 highlights
- Editorial Board appointment: appointed in 2026 to the Editorial Board of Cardiovascular Medicine (MDPI).
- EACTS Update Symposium 2026 (Zurich): spearheaded the symposium following the EACTS Annual Meeting, bringing international advances in robotic, valve, aortic and coronary surgery into clinical practice.
- Key 2026 publications: co-authored the editorial “Future of Heart Valve Surgery: Enhancing Outcomes with Innovative Technologies” in Frontiers in Cardiovascular Medicine (September 2026), alongside comparative studies on partial upper sternotomy versus right thoracotomy for surgical aortic valve replacement (August 2026) and cannulation strategies for minimally invasive mitral valve surgery (July 2026).
Role at AlbPhD Circle
Strategic clinical leadership, surgical innovation, hospital partnerships and international medical symposia.
Clinical Medicine & Translational ResearchNanobiosensors & precision diagnostics
Prof. Dr. Arben Merkoçi
ICREA Research Professor and Director of the Nanobioelectronics and Biosensors Group, ICN2 — Spain
Biography
Prof. Dr. Arben Merkoçi is an ICREA Research Professor and Director of the Nanobioelectronics and Biosensors Group at the Catalan Institute of Nanoscience and Nanotechnology (ICN2), based at the Autonomous University of Barcelona in Spain, and Co-Founder of the NanoBalkan regional research initiative. His research integrates nanomaterials, graphene, electrochemistry and printed electronics into low-cost, rapid diagnostic platforms for clinical healthcare, environmental monitoring and global health. He is a coordinator and partner in European Commission (Horizon Europe, ERC, FET) projects and deep-tech spin-offs.
Core expertise
Nanobiosensors, electrochemistry, laser-fabricated graphene electrodes, therapeutic drug monitoring, paper-based point-of-care devices, lab-on-a-chip diagnostics.
2026 highlights
- Pediatric oncology biosensing (Small Science, 2026): published “Quantum-Capacitance Biosensing Enables Real-Time Monitoring of Naxitamab for Therapeutic Response Stratification in Neuroblastoma” with the Pediatric Cancer Center Barcelona and Hospital Sant Joan de Déu, achieving femtomolar drug detection in patient-derived samples.
- Accessible anaemia diagnostics (Biosensors and Bioelectronics, 2026): a scalable electrochemical method to quantify haemoglobin from 1 µL of whole blood, supporting low-cost point-of-care testing in resource-limited settings.
Role at AlbPhD Circle
European grant consortia (Horizon Europe), biosensor innovation, translational diagnostics and NanoBalkan synergies.
Bioengineering, Diagnostics & MedTechStem cell science & regenerative medicine
Prof. Dr. Majlinda Lako
Professor of Stem Cell Sciences and Co-Director of Regenerative Medicine, Stem Cells and Transplantation, Newcastle University — United Kingdom
Biography
Prof. Dr. Majlinda Lako is a Professor of Stem Cell Sciences at Newcastle University’s Biosciences Institute in the United Kingdom, where she also serves as Co-Director of Regenerative Medicine, Stem Cells and Transplantation. An internationally recognized leader in pluripotent stem cell biology and genetic eye disease modeling, she bridges fundamental laboratory discoveries with clinical translation. She has served on major UK and European funding panels, coordinated multinational biomedical research consortia, and mentors early-career life scientists across Europe.
Core expertise
Human induced pluripotent stem cells (iPSCs), light-responsive 3D retinal organoids, limbal stem cell transplantation, gene correction, photoreceptor regeneration.
2026 highlights
- Clinical vision restoration: with clinical partners, her team established a stem cell-based transplantation approach for severe limbal stem cell deficiency that has treated 34 patients, substantially improving their vision and quality of life.
- Light-responsive retinal organoids & gene therapy: laboratory-grown 3D human retinal organoids that reproduce human retinal development and respond to light, serving as preclinical models for retinitis pigmentosa, age-related macular degeneration, gene correction and photoreceptor transplantation.
Role at AlbPhD Circle
Fundamental life sciences, stem cell and translational biomedicine, and UK–EU research mentorship.
Life Sciences & BiomedicineCompetition law, governance & legal scholarship
Dr. iur., LL.M. Pranvera Këllezi
Swiss Attorney-at-Law, Këllezi Legal; Member of the Swiss Competition Commission (COMCO) — Switzerland
Biography
Dr. iur. Pranvera Këllezi, LL.M. (College of Europe, Bruges) is an independent Swiss attorney-at-law in Geneva, a published legal scholar, and a Federal Council-appointed member of the Swiss Competition Commission (COMCO). She advises international organizations, businesses and non-profits on Swiss and European competition law, digital platform regulation, intellectual property rights and corporate governance. Her work across legal practice, university teaching and scholarship fosters continuous dialogue between legal professionals, regulatory authorities and the international academic community.
Core expertise
EU and Swiss competition law, antitrust, European market and digital economy regulation, unfair commercial practices, intellectual property, corporate governance, data protection (FADP / GDPR).
2026 highlights
- Jacques Lassier Prize international jury (2026): served for the second time on the jury of the prize organized by the International League of Competition Law (LIDC), evaluating doctoral dissertations on competition law, antitrust, unfair commercial practices and intellectual property.
Role at AlbPhD Circle
Institutional governance, consortium IP frameworks, regulatory compliance, ethics and academic evaluation.
Institutional Governance & PolicyArtificial intelligence & software technology
Prof. Dr. Mira Mezini
Full Professor of Computer Science and Head of the Software Technology Lab, TU Darmstadt; Co-Director, hessian.AI — Germany
Biography
Prof. Dr. Mira Mezini is a Full Professor of Computer Science at Technische Universität Darmstadt, where she leads the Software Technology Lab, serves as Founding Co-Director of hessian.AI (the Hessian Center for Artificial Intelligence) and acts as Co-Spokesperson of the Excellence Cluster “Reasonable Artificial Intelligence”. She has authored over 200 peer-reviewed publications; her distinctions include an ERC Advanced Grant (2012), election as an ACM Fellow, and membership in the German National Academy of Sciences Leopoldina, acatech and Academia Europaea. Beyond her research, she plays an influential role in European scientific governance and research funding committees.
Core expertise
Reliable distributed software systems, automated software analysis, foundational code models, programming languages, cybersecurity, trustworthy AI.
2026 highlights
- Dahl-Nygaard Prize & Excellence Cluster leadership: recipient of the 2025 Dahl-Nygaard Prize for outstanding contributions to object-oriented programming, and leading 2026 research on reliable distributed software systems, automated software analysis and foundational code models.
Role at AlbPhD Circle
AI research strategy, European funding governance, digital infrastructure and AI-meets-life-sciences initiatives.
AI & Data ScienceVisceral oncology & clinical trials
PD Dr. med. Dr. sc. nat. Perparim Limani
Chief Physician (Chefarzt), Clinical Director and Head of the Visceral Oncology Center, Kantonsspital Aarau — Switzerland
Biography
PD Dr. med. Dr. sc. nat. Perparim Limani is Chief Physician, Clinical Director and Head of the Visceral Oncology Center at Kantonsspital Aarau (KSA). Holding both a medical doctorate (MD) and a PhD in natural sciences, alongside international postdoctoral training at MD Anderson Cancer Center (Houston), he bridges high-volume minimally invasive and robotic visceral surgery with translational oncology research. He leads national and international clinical studies investigating novel anti-hypoxic cancer therapeutics, robotic surgical training curricula and multimodal surgical prehabilitation.
Core expertise
Hepatopancreatobiliary (HPB) and robotic visceral surgery, tumor hypoxia therapeutics (ITPP), multicenter clinical oncology trials, surgical prehabilitation, surgical innovation.
2026 highlights
- Multicenter oncology trials & robotic surgery leadership (2026): clinical trial coordination, visceral oncology center leadership and robotic surgery research programs at Kantonsspital Aarau with Swiss and European academic partners.
Role at AlbPhD Circle
Clinical trial design, translational oncology, surgical innovation and MD/PhD academic career pathways.
Clinical Medicine & Translational ResearchPrecision neurotechnology & MedTech innovation
Dr. phil. Bekim Osmani
Co-Founder, Chairman and Group CEO, Bottneuro AG; Co-Lead, Personalized Brain Implants (PBI) Flagship Initiative, University of Basel — Switzerland
Biography
Dr. phil. Bekim Osmani is Co-Founder, Chairman and Group CEO of Bottneuro AG, a Swiss MedTech spin-off from the University of Basel developing personalized neurotechnology for brain health. Drawing on his doctorate in Nanosciences and neural-interface research at the University of Basel’s Department of Biomedical Engineering, he translates academic advances into clinical healthcare solutions. He leads the development of MIAMIND®, an MRI-personalized, 3D-printed non-invasive neurostimulator designed for home-based electrical stimulation of brain networks associated with memory, attention and executive function.
Core expertise
Personalized neuromodulation (MIAMIND®), MRI-guided custom brain implants, Alzheimer’s disease clinical trials, neural-interface engineering, MedTech spin-off commercialization.
2026 highlights
- Innosuisse-funded Alzheimer’s clinical trial (MIAMIND®): leading a three-year, randomized, sham-controlled trial in patients with early-stage Alzheimer’s disease with Dr. Jessica Peter (University of Bern) and the University Psychiatric Services Bern (UPD).
- Personalized Brain Implants (PBI) flagship consortium: co-leading the multiyear initiative at the University of Basel’s Department of Biomedical Engineering with clinical Co-PI Prof. Raphael Guzman (University Hospital Basel), developing custom MRI-derived brain implants for focal epilepsy, treatment-resistant depression, Alzheimer’s and Parkinson’s disease, and glioblastoma.
Role at AlbPhD Circle
MedTech spin-off translation, clinical neurotechnology trials, patent strategy and academic–industry consortia.
Bioengineering, Diagnostics & MedTech

